CASTLE BIOSCIENCES INC (CSTL)

US14843C1053 - Common Stock

23.68  -0.11 (-0.46%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
94.1M
50.32%		137M
45.59%		219.788M
60.43%		241.98M
10.10%
EBITDA
YoY % growth
-36.69M
-508.46%		-80.66M
-119.84%		-55.647M
31.01%		-58.088M
-4.39%		N/AN/AN/A
EBIT
YoY % growth
-40.1M
-516.92%		-91.2M
-127.43%		-67.977M
25.46%		-70.828M
-4.19%
Operating Margin
-42.61%-66.57%-30.93%-29.27%
EPS
YoY % growth
-1.23
-119.64%		-2.58
-109.76%		-2.16
16.28%		-2.18
-1.14%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.70
0.30%
Revenue
Q2Q % growth		56.319M
12.32%
EBITDA
Q2Q % growth		-11.832M
EBIT
Q2Q % growth		-21.183M
-0.11%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 -0.09
91.82%		-0.340.2573.41%
Q4 2023
Q2Q % growth		 -0.10
87.18%		-0.550.4581.72%
Q3 2023
Q2Q % growth		 -0.26
66.23%		-0.780.5266.62%
Q2 2023
Q2Q % growth		 -0.70
-1,066.67%		-0.930.2325.00%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 72.974M
73.58%		67.523M5.451M8.07%
Q4 2023
Q2Q % growth		 66.12M
72.46%		57.407M8.713M15.18%
Q3 2023
Q2Q % growth		 61.49M
66.14%		49.493M11.997M24.24%
Q2 2023
Q2Q % growth		 50.14M
43.92%		45.078M5.062M11.23%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.82% 60.81% 5.81% 27.43%
Revenue0.59% 38.06% 0% 10.56%